Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Protagenic Therapeutics stock

Learn how to easily invest in Protagenic Therapeutics stock.

Protagenix Therapeutics is currently trading as an over-the-counter stock. But the company plans to launche on the New York Stock Exchange (NYSE) soon, which will make it easier for everyday investors to buy in.

How to buy Protagenic Therapeutics stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – PTIX. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Protagenic Therapeutics stock price (NASDAQ: PTIX)

Use our graph to track the performance of PTIX stocks over time.

Protagenic Therapeutics shares at a glance

Information last updated 2023-01-23.
Latest market close$0.59
52-week range$0.33 - $1.23
50-day moving average $0.49
200-day moving average $0.65
Wall St. target price$4.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.29

Buy Protagenic Therapeutics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Protagenic Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Protagenic Therapeutics price performance over time

Historical closes compared with the close of $0.59 from 2023-01-27

1 week (2023-01-23) 5.36%
1 month (2022-12-30) 47.50%
3 months (2022-10-28) 0.59
6 months (2022-07-29) 0.59
1 year (2022-01-28) -46.36%
2 years (2021-01-28) -85.78%
3 years (2020-01-30) 1.4101
5 years (2018-01-26) N/A

Protagenic Therapeutics financials

Gross profit TTM $0
Return on assets TTM -23.63%
Return on equity TTM -43.31%
Profit margin 0%
Book value $0.43
Market capitalisation $9.7 million

TTM: trailing 12 months

Protagenic Therapeutics share dividends

We're not expecting Protagenic Therapeutics to pay a dividend over the next 12 months.

Have Protagenic Therapeutics's shares ever split?

Protagenic Therapeutics's shares were split on a 1:15464 basis on 27 July 2016. So if you had owned 15464 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Protagenic Therapeutics shares – just the quantity. However, indirectly, the new 1546300% higher share price could have impacted the market appetite for Protagenic Therapeutics shares which in turn could have impacted Protagenic Therapeutics's share price.

Protagenic Therapeutics share price volatility

Over the last 12 months, Protagenic Therapeutics's shares have ranged in value from as little as $0.33 up to $1.23. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Protagenic Therapeutics's is 0.0572. This would suggest that Protagenic Therapeutics's shares are less volatile than average (for this exchange).

To put Protagenic Therapeutics's beta into context you can compare it against those of similar companies.

Protagenic Therapeutics overview

Protagenic Therapeutics, Inc. , a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York. .

Frequently asked questions

What percentage of Protagenic Therapeutics is owned by insiders or institutions?
Currently 21.197% of Protagenic Therapeutics shares are held by insiders and 9.014% by institutions.
When does the fiscal year end for Protagenic Therapeutics?
Protagenic Therapeutics's fiscal year ends in December.
Where is Protagenic Therapeutics based?
Protagenic Therapeutics's address is: 149 Fifth Avenue, New York, NY, United States, 10010
What is Protagenic Therapeutics's ISIN number?
Protagenic Therapeutics's international securities identification number is: US74365N1037
What is Protagenic Therapeutics's CUSIP number?
Protagenic Therapeutics's Committee on Uniform Securities Identification Procedures number is: 71376K102

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site